Physician profile
Jonathan E Brown
NPI 1306151634
$1,145.12
in general payments reported to CMS, 2019-2025
21 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $447 · 2022: $459 · 2023: $30.65 · 2024: $16.63 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $203.70 | 2021-2025 | Dragonfly Opstar |
| Amgen INC. | $144.46 | 2021-2022 | |
| Abbvie INC. | $114.37 | 2021-2022 | |
| Novo Nordisk INC | $87.20 | 2021-2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $83.12 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $74.13 | 2021-2022 | |
| Lilly USA, LLC | $57.76 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $57.54 | 2022 | |
| Lucid Diagnostics INC. | $53.01 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.97 | 2021-2022 | |
| Seqirus USA INC | $39.03 | 2022 | |
| Gilead Sciences, INC. | $28.32 | 2021 | |
| Astellas Pharma US INC | $26.53 | 2025 | Xtandi |
| Sanofi Pasteur INC. | $23.80 | 2022 | |
| Pfizer INC. | $17.71 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16.63 | 2024 | |
| Medtronic, INC. | $16.59 | 2023 | Venaseal |
| Noven Therapeutics, LLC | $16.21 | 2022 | |
| Jazz Pharmaceuticals INC. | $13.94 | 2021 | |
| Genentech USA, INC. | $13.09 | 2021 | |
| Eisai INC. | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.